Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- Status
- RECRUITING
- Phase
- NA
A Performance Study of (Opportunistic) Salpingectomy
- Status
- COMPLETED
- Phase
- NA
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
- Status
- RECRUITING
- Phase
- N/A
A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
- Status
- RECRUITING
- Phase
- N/A
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Project CADENCE (CAncer Detected Early caN be CurEd)
- Status
- UNKNOWN
- Phase
- N/A
A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
- Status
- UNKNOWN
- Phase
- PHASE1
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
- Status
- RECRUITING
- Phase
- N/A
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)
- Status
- RECRUITING
- Phase
- PHASE4
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Genetic Testing in African Americans
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2